Home > Cashflow Statement > GLAND PHARMA

GLAND PHARMA
Cashflow Statement

GLAND PHARMA is part of below Screeners ↓
Top Small Cap Stocks with Best Fundamentals
Top Undervalued Small Cap Stocks
Best Quarterly Growth Small Cap Stocks
AD     Remove this Ad

GLAND PHARMA Last 5 Year Cashflow Statement History

[Consolidated]

Mar2025Mar2024Mar2023Mar2022Mar2021
Profit Before Tax₹1,063 Cr₹1,133 Cr₹1,055 Cr₹1,619 Cr₹1,335 Cr
Adjustment ₹212 Cr₹224 Cr₹38 Cr₹-28 Cr₹17 Cr
Changes In working Capital ₹-6.06 Cr₹-53 Cr₹-418 Cr₹-393 Cr₹-436 Cr
Cash Flow after changes in Working Capital ₹1,269 Cr₹1,303 Cr₹675 Cr₹1,197 Cr₹916 Cr
Cash Flow from Operating Activities ₹915 Cr₹997 Cr₹364 Cr₹791 Cr₹605 Cr
Cash Flow from Investing Activities ₹1,705 Cr₹-1,757 Cr₹1,208 Cr₹-1,003 Cr₹-1,524 Cr
Cash Flow from Financing Activities ₹-433 Cr₹-799 Cr₹15 Cr₹35 Cr₹1,238 Cr
Net Cash Inflow / Outflow ₹2,186 Cr₹-1,560 Cr₹1,587 Cr₹-177 Cr₹319 Cr
Opening Cash & Cash Equivalents ₹357 Cr₹1,909 Cr₹319 Cr₹492 Cr₹169 Cr
Cash & Cash Equivalent on Amalgamation / Take over / Merger -----
Cash & Cash Equivalent of Subsidiaries under liquidations -----
Translation adjustment on reserves / op cash balalces frgn subsidiaries -----
Effect of Foreign Exchange Fluctuations ₹13 Cr₹7.72 Cr₹3.00 Cr₹3.31 Cr₹3.58 Cr
Closing Cash & Cash Equivalent ₹2,556 Cr₹357 Cr₹1,909 Cr₹319 Cr₹492 Cr

Compare Cashflow Statement of peers of GLAND PHARMA

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
GLAND PHARMA ₹27,850.4 Cr 2.3% -8.6% 3.8% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹406,603.0 Cr -1.4% -3.2% -0.5% Stock Analytics
DIVIS LABORATORIES ₹155,485.0 Cr -1.9% -8.7% 1.9% Stock Analytics
TORRENT PHARMACEUTICALS ₹135,009.0 Cr -3.5% -6.6% 30.6% Stock Analytics
DR REDDYS LABORATORIES ₹101,628.0 Cr -4% -8.3% 6.3% Stock Analytics
CIPLA ₹96,400.8 Cr -1.9% -11.9% -19% Stock Analytics


GLAND PHARMA Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
GLAND PHARMA

2.3%

-8.6%

3.8%

SENSEX

-1%

-10.9%

-6%


You may also like the below Video Courses